EUROPEAN CORPORATE BOND PIPELINE
GlobalCapital's latest information on forthcoming and planned corporate bond issues in the European market.
|Sanofi||Plans to finance the $11.6bn acquisition of Bioverativ with a combination of cash on hand and through new debt to be raised||French pharmaceuticals company rated A1/AA |
|BWP Project Services ||£ Sub-benchmark 18.5yr amortising bond (11yr WAL) ||Mandated
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: email@example.com
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: firstname.lastname@example.org or find out more online here.
Want full access to GlobalCapital?
If you are new to GlobalCapital or you already subscribe to some of our channels you can still easily extend your access.
Take a trial to the entire site or subscribe online to see all our capital markets news, opinion and data sets.
Don't miss out!
Read the magazine on your mobile device
Latest news by market and league table performance
See full list
Bookrunners of Euro Denominated Corporate IG Bonds
Bookrunners of European HY Bonds
Bookrunners of Dollar Denominated HY Bonds
Bookrunners of European Corporate IG Bonds